Guangdong Lifestrong Pharmacy Co. Ltd. (301111) — Net Asset Quality Index
Guangdong Lifestrong Pharmacy Co. Ltd. (301111) has a Net Asset Quality Index of 81.3% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥925.41 Million minus total liabilities of CN¥172.75 Million yields net assets of CN¥752.66 Million. A higher index indicates a stronger, lower-leverage balance sheet. See 301111 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Guangdong Lifestrong Pharmacy Co. Ltd. Net Asset Quality Index Over Time (2017–2024)
This chart shows how Guangdong Lifestrong Pharmacy Co. Ltd.'s Net Asset Quality Index has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the index stands at 81.3%, representing net assets of CN¥752.66 Million against total assets of CN¥925.41 Million CNY. Explore how efficiently does Guangdong Lifestrong Pharmacy Co. Ltd. generate cash to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Guangdong Lifestrong Pharmacy Co. Ltd. (2017–2024)
The table below presents the year-by-year Net Asset Quality Index for Guangdong Lifestrong Pharmacy Co. Ltd. from 2017 to 2024, covering 8 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Guangdong Lifestrong Pharmacy Co. Ltd. stock valuation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 82.2% | CN¥766.75 Million | CN¥933.17 Million | CN¥166.42 Million | ▼ -8.8 pp |
| 2023 | 91.0% | CN¥778.21 Million | CN¥855.54 Million | CN¥77.33 Million | ▲ +2.4 pp |
| 2022 | 88.5% | CN¥758.67 Million | CN¥857.06 Million | CN¥98.39 Million | ▼ -2.4 pp |
| 2021 | 90.9% | CN¥750.85 Million | CN¥826.20 Million | CN¥75.34 Million | ▲ +6.6 pp |
| 2020 | 84.3% | CN¥323.41 Million | CN¥383.78 Million | CN¥60.37 Million | ▲ +0.7 pp |
| 2019 | 83.5% | CN¥271.68 Million | CN¥325.26 Million | CN¥53.57 Million | ▲ +6.3 pp |
| 2018 | 77.3% | CN¥229.97 Million | CN¥297.61 Million | CN¥67.64 Million | ▲ +18.0 pp |
| 2017 | 59.2% | CN¥166.37 Million | CN¥280.91 Million | CN¥114.55 Million | — |